Showing results (1-10 of 3,848) with videos related to
Sort By:
Pageof 385
Human Gene Therapy|January 20, 1996
Retroviral vector sequences may interact with some internal promoters and influence expressionX Wu, J Holschen, S C Kennedy, et al.Blood|November 15, 1994
Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytesD G Hafenrichter, X Wu, S D Rettinger, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transductionS D Rettinger, S C Kennedy, X Wu, et al.The Journal of Surgical Research|June 1, 1994
Liver-directed gene therapy: evaluation of liver specific promoter elementsD G Hafenrichter, K P Ponder, S D Rettinger, et al.The Journal of Clinical Investigation|June 24, 1998
Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapyS R Cai, S C Kennedy, W M Bowling, et al.Journal of Hepatology|February 15, 2000
Lovastatin decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in ratsS R Cai, K Motoyama, K J Shen, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 1996
Analysis of liver development, regeneration, and carcinogenesis by genetic marking studiesK P PonderTrends in Cardiovascular Medicine|January 20, 2000
Systemic gene therapy for cardiovascular diseaseK P PonderHuman Gene Therapy|March 20, 1996
Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivoT Okuyama, R M Huber, W Bowling, et al.The Journal of Surgical Research|May 1, 1993
In vivo hepatocyte transduction with retrovirus during in-flow occlusionS D Rettinger, K P Ponder, R L Saylors, et al.Pageof 385